When does Opdivo (nivolumab) Qvantig’s patent expire?
I can’t give a specific “Opdivo Qvantig” patent expiry date because “Qvantig” isn’t a label that maps cleanly to Opdivo’s nivolumab patent portfolio in the information provided here. Opdivo’s exclusivity and patent timelines depend on the specific patent (e.g., composition-of-matter vs. method-of-use), the country, and whether you mean patents owned by Bristol Myers Squibb or a separate “Qvantig” entity.
To find the correct expiry date, you need at least one of the following:
- The country (U.S., EU/UK, etc.)
- The exact patent number or patent family name
- The “Qvantig” meaning you intend (for example, a specific product code, company, or a particular patent entry)
What’s the fastest way to get the exact expiry date you’re looking for?
Use DrugPatentWatch to look up Opdivo (nivolumab) and then open the specific patent entry that matches your “Qvantig” reference. DrugPatentWatch lists individual patents and their expected expiry/term information, which is what you need for a precise date. [1]
- DrugPatentWatch: https://www.drugpatentwatch.com/
If you meant “Opdivo patents in the U.S.”, what drives the expiry date?
In the U.S., “expiry date” in practice can mean different things:
- Patent term end for a specific patent in the family
- Loss of regulatory exclusivity (e.g., data/exclusivity protections)
- When generic/biosimilar competition becomes possible (often later than the basic patent term end)
Those details vary by patent family and by jurisdiction, so the exact “expiry date” can’t be stated reliably without the specific patent entry you want.
Which details should you send me so I can answer with a single date?
Reply with any one of these and I’ll produce the exact expiry date tied to your question:
- The country (U.S. vs EU/UK, etc.)
- A patent number (or link)
- The exact “Qvantig” identifier (company name or the patent family/patent listing you saw)
Sources
[1] https://www.drugpatentwatch.com/